Car T-cell therapy, described as a “living drug,” is now available for patients with relapsed/refractory multiple myeloma who have been treated with four or more
Read more
Home ยป
Car T-cell therapy, described as a “living drug,” is now available for patients with relapsed/refractory multiple myeloma who have been treated with four or more
Read moreLarge Granular Lymphocytic Leukemia (LGLL) is a rare cancer of one type of white blood cells, with less than 1000 new cases reported in the
Read more